Filter
155
Text search:
patent
Featured
Recommendations
17
New Publications
39
Language
Document type
No document type
72
Guidelines
30
Studies & Reports
29
Manuals
10
Strategic & Response Plan
6
Fact sheets
5
Training Material
2
Resource Platforms
1
Countries / Regions
Nigeria
13
India
8
Global
4
South Africa
3
Sierra Leone
2
Ethiopia
2
Ghana
2
Uganda
2
Nepal
2
Kenya
2
Rwanda
2
Malawi
2
Asia
2
Congo, Democratic Republic of
1
Cameroon
1
Zimbabwe
1
Philippines
1
Pakistan
1
Germany
1
Zambia
1
Bangladesh
1
Papua New Guinea
1
Sudan
1
Ukraine
1
Botswana
1
Lesotho
1
Myanmar / Burma
1
Western and Central Europe
1
Africa
1
Eastern Europe
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
43
Clinical Guidelines
26
Women & Child Health
13
Public Health
8
Pharmacy & Technologies
6
Key Resources
5
Capacity Building
1
Toolboxes
HIV
22
COVID-19
13
Pharmacy
13
AMR
11
TB
9
Caregiver
8
Global Health Education
5
Mental Health
4
NTDs
4
Rapid Response
3
NCDs
2
Malaria
2
Disability
1
Ebola & Marburg
1
Conflict
1
Natural Hazards
1
Refugee
1
Zika
1
Specific Hazards
1
Planetary Health
1
Health Financing Toolbox
1
Policy Brief
Accessed: 20.11.2019
23 February 2022
A summary of the commitments and targets within the United Nations General Assembly’s 2021 Political Declaration on HIV and AIDS.The United Nations General Assembly’s 2021 Political Declaration on AIDS features bold global commitments and targets for 2025 that are ambitious but
...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug
...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
Entwicklungen und gegenwärtige Situationen der Covid-19-Impfstoffe
26 July 2021
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis moves up into 2nd. Takeda rises furthest in 20
...